Sun Pharmaceutical Industries Limited
NSE: SUNPHARMA BSE: SUNPHARMA
NSE
1,640.90
18.70 (1.15%)
Prev Close
1622.2
Open Price
1624.2
Volume
1,313,620
Today Low / High
1617.3 / 1643.5
52 WK Low / High
1553.05 / 1960.35
Range
1,559 - 1,723
BSE
1,639.55
17.55 (1.08%)
Prev Close
1622
Open Price
1637.6
Volume
12,242
Today Low / High
1619.6 / 1642.4
52 WK Low / High
1555 / 1960.2
Range
1,558 - 1,722
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1640.9 (target range: 1,559 - 1,723), reflecting a change of 18.7 (1.15276%). On the BSE, it is listed at 1639.55 (target range: 1,558 - 1,722), showing a change of 17.55 (1.082%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
12 Aug
1,611.70
0.65%
11 Aug
1,586.90
1.35%
08 Aug
1,590.00
-0.19%
07 Aug
1,581.00
1.10%
06 Aug
1,629.70
-2.12%
05 Aug
1,640.90
-0.54%
04 Aug
1,629.80
0.72%
01 Aug
1,690.00
-3.57%
31 Jul
1,715.50
-0.51%
30 Jul
1,720.00
0.80%
29 Jul
1,698.00
0.74%
28 Jul
1,702.10
0.01%
25 Jul
1,690.00
0.53%
24 Jul
1,682.50
0.56%
23 Jul
1,678.50
0.24%
22 Jul
1,686.10
-0.48%
21 Jul
1,681.10
0.67%
Sun Pharmaceutical Industries Limited Graph
Sun Pharmaceutical Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sun Pharmaceutical Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,640.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,639.55 | 1,655.95 | 1,490.35 - 1,821.54 |
| 1,672.34 | 1,337.87 - 2,006.81 | ||
| 1,688.74 | 1,182.12 - 2,195.36 | ||
| Bearish Scenario | 1,639.55 | 1,623.15 | 1,460.84 - 1,785.47 |
| 1,606.76 | 1,285.41 - 1,928.11 | ||
| 1,590.36 | 1,113.25 - 2,067.47 |
Overview of Sun Pharmaceutical Industries Limited
ISIN
INE044A01036
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
2,462,164
Market Cap
3,892,112,016,000
Last Dividend
16
Official Website
IPO Date
1996-01-01
DCF Diff
-2,567.95
DCF
4,190
Financial Ratios Every Investor Needs
Stock Dividend of SUNPHARMA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-07 | July 07, 25 | 5.5 | 5.5 | 2025-07-07 | 2025-08-08 | |
| 2025-02-06 | February 06, 25 | 10.5 | 10.5 | 2025-02-06 | 2025-02-20 | |
| 2024-07-12 | July 12, 24 | 5 | 5 | 2024-07-12 | 2024-08-16 | |
| 2024-02-09 | February 09, 24 | 8.5 | 8.5 | 2024-02-09 | 2024-02-23 | |
| 2023-07-28 | July 28, 23 | 4 | 4 | 2023-07-28 | 2023-09-08 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 52,041.25 Cr | 23,771.91 Cr | 28,381.30 Cr | 0.5454 | 3,154.19 Cr | 3,723.59 Cr | 12,445.19 Cr | 10,929.04 Cr | 45.60 | 15,086.16 Cr | 0.2100 |
| 2024-03-31 | 47,758.45 Cr | 24,812.11 Cr | 22,946.34 Cr | 0.4805 | 3,127.70 Cr | 3,437.14 Cr | 10,468.18 Cr | 9,576.38 Cr | 39.91 | 13,836.33 Cr | 0.2005 |
| 2023-03-31 | 43,278.87 Cr | 10,662.16 Cr | 32,616.71 Cr | 0.7536 | 2,307.72 Cr | 2,818.46 Cr | 9,304.75 Cr | 8,473.58 Cr | 35.32 | 12,084.93 Cr | 0.1958 |
| 2022-03-31 | 38,426.42 Cr | 11,707.65 Cr | 26,718.77 Cr | 0.6953 | 2,132.51 Cr | 2,186.83 Cr | 8,147.17 Cr | 3,272.73 Cr | 13.64 | 6,699.65 Cr | 0.0852 |
| 2021-03-31 | 33,139.18 Cr | 9,885.42 Cr | 23,253.76 Cr | 0.7017 | 2,102.82 Cr | 2,385.26 Cr | 6,427.62 Cr | 2,903.82 Cr | 12.10 | 4,998.62 Cr | 0.0876 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11,331.62 Cr | 92,100.58 Cr | 19,614.63 Cr | 72,218.0200 Cr | 2,362.19 Cr | -8,969.43 Cr | 10,243.33 Cr | 11,270.28 Cr | 0.00 Cr | 376.74 Cr | 4,697.70 Cr | 18,194.2100 Cr |
| 2024-03-31 | 9,285.65 Cr | 85,462.88 Cr | 18,356.91 Cr | 63,666.7500 Cr | 3,273.67 Cr | -6,011.98 Cr | 10,294.89 Cr | 11,300.05 Cr | 126.54 Cr | 489.37 Cr | 6,441.23 Cr | 16,984.4000 Cr |
| 2023-03-31 | 4,623.73 Cr | 80,743.59 Cr | 21,428.12 Cr | 55,995.3800 Cr | 6,889.66 Cr | 2,265.93 Cr | 10,513.05 Cr | 11,353.73 Cr | 7,256.18 Cr | 343.53 Cr | 5,457.48 Cr | 19,906.3800 Cr |
| 2022-03-31 | 4,508.25 Cr | 69,799.87 Cr | 18,733.76 Cr | 48,011.2200 Cr | 1,290.30 Cr | -3,217.95 Cr | 8,996.81 Cr | 11,168.89 Cr | 11,402.24 Cr | 618.75 Cr | 4,959.21 Cr | 17,200.5500 Cr |
| 2021-03-31 | 6,273.03 Cr | 67,666.73 Cr | 18,186.90 Cr | 46,462.7800 Cr | 3,868.58 Cr | -2,404.45 Cr | 8,997.02 Cr | 11,171.51 Cr | 8,687.82 Cr | 718.55 Cr | 6,482.39 Cr | 16,145.6300 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 14,072.0900 Cr | -5,306.1600 Cr | -7,905.8200 Cr | 11,943.5100 Cr | 983.1200 Cr | 10,268.7700 Cr | -2,128.5800 Cr | 10,929.0400 Cr | -1,030.3400 Cr | -3,613.9700 Cr | -183.9700 Cr |
| 2024-03-31 | 12,134.9800 Cr | -690.2000 Cr | -6,710.1600 Cr | 9,933.1700 Cr | 4,661.9200 Cr | 9,285.6500 Cr | -2,201.8100 Cr | 9,576.3800 Cr | -3,389.9300 Cr | -2,898.1700 Cr | 598.8100 Cr |
| 2023-03-31 | 4,959.3300 Cr | -7,943.6800 Cr | 2,376.0700 Cr | 2,873.7500 Cr | 115.4800 Cr | 4,623.7300 Cr | -2,085.5800 Cr | 9,408.4300 Cr | 5,129.6600 Cr | -2,518.8800 Cr | -1,202.2000 Cr |
| 2022-03-31 | 8,984.5400 Cr | -5,724.7400 Cr | -5,193.4600 Cr | 7,489.5000 Cr | -1,764.7800 Cr | 4,508.2500 Cr | -1,495.0400 Cr | 4,481.3200 Cr | -2,636.7100 Cr | -2,158.9200 Cr | 306.9500 Cr |
| 2021-03-31 | 6,170.3700 Cr | 536.2200 Cr | -5,980.4800 Cr | 5,000.2400 Cr | 596.4200 Cr | 6,273.0300 Cr | -1,170.1300 Cr | 2,799.3700 Cr | -4,371.8500 Cr | -1,559.4700 Cr | -1,080.2900 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 13,786.07 Cr | 2,814.76 Cr | 10,971.31 Cr | 0.7958 | 3,372.07 Cr | 2,278.63 Cr | 9.50 | 3,948.12 Cr | 0.1653 |
| 2025-03-31 | 12,958.84 Cr | 2,637.19 Cr | 10,321.65 Cr | 0.7965 | 7,042.73 Cr | 2,149.88 Cr | 9.00 | 3,404.91 Cr | 0.1659 |
| 2024-12-31 | 13,436.94 Cr | 2,740.54 Cr | 10,696.40 Cr | 0.7960 | 3,561.81 Cr | 2,903.38 Cr | 12.10 | 4,158.47 Cr | 0.2161 |
| 2024-09-30 | 13,291.39 Cr | 5,797.81 Cr | 7,493.58 Cr | 0.5638 | 3,184.96 Cr | 3,040.16 Cr | 12.70 | 4,292.96 Cr | 0.2287 |
| 2024-06-30 | 12,652.75 Cr | 5,785.18 Cr | 6,867.57 Cr | 0.5428 | 3,002.94 Cr | 2,835.62 Cr | 11.82 | 4,140.17 Cr | 0.2241 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11,331.62 Cr | 13,656.10 Cr | 24,987.72 Cr | 13,046.11 Cr | 10,243.33 Cr | 52,624.47 Cr | 11,270.28 Cr | 92,100.58 Cr | 19,614.63 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 20,122.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -69,379.65 Cr |
| 2024-09-30 | 8,012.54 Cr | 11,107.19 Cr | 20,755.37 Cr | 12,989.39 Cr | 9,935.65 Cr | 46,105.45 Cr | 11,248.33 Cr | 88,115.66 Cr | 18,736.01 Cr |
| 2024-06-30 | -19,090.06 Cr | 38,180.12 Cr | 19,090.06 Cr | 0.00 Cr | 0.00 Cr | 19,090.06 Cr | 0.00 Cr | 0.00 Cr | -67,105.97 Cr |
| 2024-03-31 | 10,520.68 Cr | 8,584.54 Cr | 19,105.22 Cr | 11,260.24 Cr | 9,868.29 Cr | 43,433.11 Cr | 11,300.05 Cr | 85,462.88 Cr | 18,356.91 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2,149.88 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 2,903.38 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 3,040.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2,835.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 2,654.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2013-07-29 | July 29, 13 | 2:1 |
| 2010-11-25 | November 25, 10 | 5:1 |
| 2004-05-27 | May 27, 04 | 2:1 |
| 2003-01-13 | January 13, 03 | 2:1 |
| 2000-03-08 | March 08, 00 | 3:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,640.90 | ₹3,936,978,552,000.00 | ₹1,313,620.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,100.50 | ₹1,619,493,634,500.00 | ₹394,932.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,617.80 | ₹1,224,426,321,000.00 | ₹287,405.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,253.40 | ₹1,043,245,022,805.00 | ₹1,191,889.00 |
| Mankind Pharma Limited | MANKIND | ₹2,466.00 | ₹1,017,789,122,160.00 | ₹376,033.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.60 | ₹994,758,978,000.00 | ₹1,911,246.00 |
| Lupin Limited | LUPIN | ₹1,989.80 | ₹908,835,180,600.00 | ₹875,748.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,388.50 | ₹644,276,002,500.00 | ₹899,623.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,078.20 | ₹626,220,716,400.00 | ₹444,368.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,029.30 | ₹572,670,489,300.00 | ₹466,363.00 |
| Laurus Labs Limited | LAURUSLABS | ₹863.15 | ₹465,949,948,750.00 | ₹2,817,579.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹986.05 | ₹377,230,198,238.00 | ₹177,879.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,364.60 | ₹346,204,478,400.00 | ₹113,365.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,671.70 | ₹333,791,511,200.00 | ₹40,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,715.50 | ₹268,163,529,000.00 | ₹62,276.00 |
| Piramal Enterprises Limited | PEL | ₹1,127.20 | ₹255,511,441,600.00 | ₹243,681.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,501.60 | ₹243,978,466,400.00 | ₹325,967.00 |
| Eris Lifesciences Limited | ERIS | ₹1,674.80 | ₹228,119,483,600.00 | ₹42,022.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,416.50 | ₹210,412,500,000.00 | ₹34,705.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹941.00 | ₹184,965,783,000.00 | ₹25,900.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,077.50 | ₹171,625,277,500.00 | ₹132,577.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,018.00 | ₹167,019,638,200.00 | ₹23,483.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,156.90 | ₹163,949,635,730.00 | ₹164,102.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹904.25 | ₹161,960,217,500.00 | ₹516,819.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹460.35 | ₹111,701,165,400.00 | ₹778,530.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,182.50 | ₹102,625,790,500.00 | ₹13,202.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹906.20 | ₹88,618,113,580.00 | ₹114,891.00 |
| Strides Pharma Science Limited | STAR | ₹867.30 | ₹79,941,382,710.00 | ₹568,013.00 |
| FDC Limited | FDC | ₹483.20 | ₹78,669,792,000.00 | ₹76,497.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹790.45 | ₹71,642,135,379.00 | ₹1,229,147.00 |
| Innova Captab Limited | INNOVACAP | ₹902.00 | ₹51,616,886,860.00 | ₹24,559.00 |
| Suven Life Sciences Limited | SUVEN | ₹232.25 | ₹50,647,686,500.00 | ₹235,893.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹142.28 | ₹46,172,990,160.00 | ₹192,243.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹488.05 | ₹44,544,323,500.00 | ₹79,719.00 |
| Sequent Scientific Limited | SEQUENT | ₹171.51 | ₹42,934,955,850.00 | ₹221,470.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹768.10 | ₹38,957,340,710.00 | ₹102,241.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,281.60 | ₹37,735,382,400.00 | ₹9,674.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹513.80 | ₹36,174,500,040.00 | ₹45,592.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹356.70 | ₹35,769,162,600.00 | ₹36,115.00 |
| Hikal Limited | HIKAL | ₹255.65 | ₹31,521,900,650.00 | ₹589,191.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹605.30 | ₹29,147,010,900.00 | ₹54,573.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹93.23 | ₹27,365,522,210.00 | ₹1,598,864.00 |
| Indoco Remedies Limited | INDOCO | ₹293.70 | ₹27,093,208,230.00 | ₹138,144.00 |
| Alembic Limited | ALEMBICLTD | ₹105.19 | ₹27,010,898,475.00 | ₹451,825.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹47.31 | ₹25,923,703,740.00 | ₹3,167,804.00 |
Key Executives
Vice President, Head of Investor Relations & Strategic Projects
Dr. Abhishek Sharma
Gender: Not Specified
Year Born:
Company Secretary & Compliance Officer
Mr. Anoop Deshpande
Gender: male
Year Born:
Chief Human Resources Officer
Mr. Suresh Kumar Rai
Gender: male
Year Born:
Chief Operating Officer, Head of Global Generics R&D, Business Devp., and Whole Time Director
Mr. Aalok Dilip Shanghvi
Gender: male
Year Born: 1984
Chief Financial Officer
Mr. C. S. Muralidharan ICWA, M.Com
Gender: male
Year Born: 1963
Director of Corporate Development
Mr. Kalyanasundaram Subramanian
Gender: male
Year Born: 1954
MD & Chairman of the Board
Mr. Dilip Shantilal Shanghvi
Gender: male
Year Born: 1955
Head of India Business
Mr. Kirti Wardhaman Ganorkar
Gender: male
Year Born: 1967
Chief Executive Officer of North America Business
Mr. Abhay Gandhi
Gender: male
Year Born: 1965
EVice President & Chief Information Officer
Mr. Dheeraj Prasad Sinha BE
Gender: male
Year Born: 1971
FAQs about Sun Pharmaceutical Industries Limited
Who is the CEO of the company?
The CEO is Abhay Gandhi.
What is the current market price of the stock?
The current price is ₹1,622.20.
What is the 52-week price range?
The range is ₹1553.05-1960.35.
What is the market capitalization of the company?
The market capitalization is ₹389,211.20 crores.
What is the dividend yield?
The dividend yield is 0.99%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 37.51.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Sun Pharmaceutical Industries Limited (ISIN: INE044A01036) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹389,211.20 crores and an average daily volume of 2,462,164 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹16.